Published in Biol Pharm Bull on June 01, 2002
Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol (2007) 1.26
A new gadolinium-based MRI zinc sensor. J Am Chem Soc (2009) 1.24
Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin. Magn Reson Med (2006) 1.14
Estimating protein-ligand binding affinity using high-throughput screening by NMR. J Comb Chem (2008) 1.12
Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 1.11
Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC). J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.10
The roles of glycated albumin as intermediate glycation index and pathogenic protein. Diabetes Metab J (2012) 1.09
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res (2013) 1.06
Albumin for end-stage liver disease. Korean J Intern Med (2012) 0.93
Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene. Mol Vis (2007) 0.92
Interaction of virstatin with human serum albumin: spectroscopic analysis and molecular modeling. PLoS One (2012) 0.92
Redox-active magnetic resonance imaging contrast agents: studies with thiol-bearing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid derivatives. J Med Chem (2012) 0.90
Enrichment of cysteinyl adducts of human serum albumin. Anal Biochem (2010) 0.90
A novel type of allosteric regulation: functional cooperativity in monomeric proteins. Arch Biochem Biophys (2012) 0.89
Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction. Anal Chem (2014) 0.89
Interactive association of drugs binding to human serum albumin. Int J Mol Sci (2014) 0.89
Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes. Drug Metab Dispos (2008) 0.88
Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling. J Chromatogr A (2011) 0.87
Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method. Biophys J (2007) 0.87
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin. J Biol Chem (2009) 0.86
Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects. Nucl Med Biol (2009) 0.86
Pollutant-induced modulation in conformation and β-lactamase activity of human serum albumin. PLoS One (2012) 0.84
Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics. Front Immunol (2015) 0.84
Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy. Int J Colorectal Dis (2009) 0.83
S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding. J Biol Chem (2008) 0.83
Probing the interaction of a therapeutic flavonoid, pinostrobin with human serum albumin: multiple spectroscopic and molecular modeling investigations. PLoS One (2013) 0.83
Albumin-based drug delivery: harnessing nature to cure disease. Mol Cell Ther (2016) 0.82
Stereoselective binding of chiral drugs to plasma proteins. Acta Pharmacol Sin (2013) 0.82
Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases. Eur J Nucl Med Mol Imaging (2008) 0.81
Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cells. Int J Nanomedicine (2011) 0.81
Small-volume resuscitation from hemorrhagic shock with polymerized human serum albumin. Am J Emerg Med (2011) 0.81
Frog albumin is expressed in skin and characterized as a novel potent trypsin inhibitor. Protein Sci (2005) 0.81
Albumin binding as a potential biomarker of exposure to moderately low levels of organophosphorus pesticides. Biomarkers (2008) 0.81
Reciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albumin. PLoS One (2013) 0.80
Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals. J Pharm Sci (2009) 0.80
Interaction of bioactive coomassie brilliant blue g with protein: insights from spectroscopic methods. Sci Pharm (2010) 0.80
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin. J Biol Inorg Chem (2010) 0.79
Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion. BMC Biotechnol (2012) 0.79
High-throughput 1,536-well fluorescence polarization assays for α(1)-acid glycoprotein and human serum albumin binding. PLoS One (2012) 0.79
Do hydration dynamics follow the structural perturbation during thermal denaturation of a protein: a terahertz absorption study. Biophys J (2011) 0.78
An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions. FEBS J (2015) 0.78
Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage. Int J Nanomedicine (2016) 0.77
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding. MAbs (2016) 0.77
Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients. Nutr J (2010) 0.77
Anticancer activity and biophysical reactivity of copper complexes of 2-(benzo[d][1,3]dioxol-5-ylmethylene)-N-alkylhydrazinecarbothioamides. Inorg Chem Commun (2012) 0.77
A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin. J Biol Inorg Chem (2006) 0.77
Affinity and specificity of levamlodipine-human serum albumin interactions: insights into its carrier function. Biophys J (2009) 0.77
Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment. Oncotarget (2014) 0.77
Study of interaction of human serum albumin with curcumin by NMR and docking. J Mol Model (2014) 0.76
Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding. J Biol Inorg Chem (2011) 0.76
Sulfation of Lower Chlorinated Polychlorinated Biphenyls Increases Their Affinity for the Major Drug-Binding Sites of Human Serum Albumin. Environ Sci Technol (2016) 0.76
Albumin fusion of interleukin-28B: production and characterization of its biological activities and protein stability. PLoS One (2013) 0.76
Reversion of sulfenamide prodrugs in the presence of free thiol-containing proteins. J Pharm Sci (2011) 0.75
Mechanistic investigation of domain specific unfolding of human serum albumin and the effect of sucrose. Protein Sci (2013) 0.75
Synthesis and structure of [(η(6)-p-cymene)Ru(2-anthracen-9-ylmethylene-N-ethylhydrazinecarbothioamide)Cl]Cl; biological evaluation, topoisomerase II inhibition and reaction with DNA and human serum albumin. Metallomics (2011) 0.75
The investigation of the binding of 6-mercaptopurine to site I on human serum albumin. Protein J (2012) 0.75
Cytotoxic gallium complexes containing thiosemicarbazones derived from 9-anthraldehyde: Molecular docking with biomolecules. J Mol Struct (2016) 0.75
Chromatographic Studies of Protein-Based Chiral Separations. Separations (2016) 0.75
Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin. PLoS One (2015) 0.75
Coordination Chemistry of Polyaromatic Thiosemicarbazones 2: Synthesis and Biological Activity of Zinc, Cobalt, and Copper Complexes of 1-(Naphthalene-2-yl)ethanone Thiosemicarbazone. Int J Inorg Chem (2011) 0.75
Refolding of SDS-Unfolded Proteins by Nonionic Surfactants. Biophys J (2017) 0.75
Natural isoquinoline alkaloids: binding aspects to functional proteins, serum albumins, hemoglobin, and lysozyme. Biophys Rev (2015) 0.75
Interaction and oxidative damage of DVDMS to BSA: a study on the mechanism of photodynamic therapy-induced cell death. Sci Rep (2017) 0.75
Site specific modification of the human plasma proteome by methylglyoxal. Toxicol Appl Pharmacol (2015) 0.75
Effect of long-chain Fatty acids on the binding of triflupromazine to human serum albumin: a spectrophotometric study. Sci Pharm (2013) 0.75
Human pharmacogenomic variations and their implications for antifungal efficacy. Clin Microbiol Rev (2006) 0.75
Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin. PLoS One (2014) 0.75
The Spectroscopy Study of the Binding of an Active Ingredient of Dioscorea Species with Bovine Serum Albumin with or without Co(2+) or Zn(2+). Evid Based Complement Alternat Med (2014) 0.75
Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization. Int J Nanomedicine (2017) 0.75
Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. PLoS One (2017) 0.75
Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol (2005) 3.00
Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney. Nephrol Dial Transplant (2011) 1.69
Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models. J Control Release (2012) 1.43
Nitrosylated human serum albumin (SNO-HSA) induces apoptosis in tumor cells. Nitric Oxide (2009) 1.42
p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int (2013) 1.31
Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res (2002) 1.31
Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther (2007) 1.24
The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim Biophys Acta (2003) 1.14
Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int (2004) 1.11
Redox properties of serum albumin. Biochim Biophys Acta (2013) 1.07
Albumin-drug interaction and its clinical implication. Biochim Biophys Acta (2013) 1.06
Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. Am J Physiol Gastrointest Liver Physiol (2008) 1.03
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int (2002) 1.02
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier. J Pharmacol Exp Ther (2004) 1.02
Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem (2002) 1.02
A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy. Kidney Int (2013) 0.97
Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. J Clin Endocrinol Metab (2005) 0.97
CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products. Am J Physiol Renal Physiol (2008) 0.97
Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. J Mol Biol (2006) 0.96
Effects of uremic serum and uremic toxins on hepatic uptake of digoxin. Ther Drug Monit (2008) 0.96
Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates. Pharm Res (2004) 0.96
Update on the pharmacokinetics and redox properties of protein-bound uremic toxins. J Pharm Sci (2011) 0.93
The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). Drug Metab Pharmacokinet (2006) 0.92
An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. Pharm Res (2007) 0.92
Antioxidant effects of a dietary supplement: reduction of indices of oxidative stress in normal subjects by water-soluble chitosan. Food Chem Toxicol (2008) 0.91
The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun (2005) 0.90
Kinetic studies of covalent binding between N-acetyl-L-cysteine and human serum albumin through a mixed-disulfide using an N-methylpyridinium polymer-based column. Drug Metab Pharmacokinet (2004) 0.88
Oxidation of Arg-410 promotes the elimination of human serum albumin. Biochim Biophys Acta (2006) 0.88
α(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress. J Biol Chem (2012) 0.88
Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res (2005) 0.87
Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats. Pharm Res (2005) 0.87
Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration. J Pharmacol Exp Ther (2003) 0.87
Functional analysis of recombinant human serum albumin domains for pharmaceutical applications. Pharm Res (2004) 0.87
Antioxidant properties of some different molecular weight chitosans. Carbohydr Res (2009) 0.86
Effect of olmesartan on oxidative stress in hemodialysis patients. Hypertens Res (2007) 0.86
Recombinant human serum albumin. Drugs Today (Barc) (2007) 0.86
Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress. Biochim Biophys Acta (2004) 0.85
Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int (2004) 0.85
Human serum albumin-thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury. J Control Release (2011) 0.85
Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin. Drug Metab Dispos (2012) 0.85
S-Nitrosylation of human variant albumin Liprizzi (R410C) confers potent antibacterial and cytoprotective properties. J Pharmacol Exp Ther (2006) 0.85
The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs. Biochim Biophys Acta (2007) 0.85
How do fatty acids cause allosteric binding of drugs to human serum albumin? Pharm Res (2002) 0.85
The antioxidative and antilipidemic effects of different molecular weight chitosans in metabolic syndrome model rats. Biol Pharm Bull (2010) 0.85
Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. J Immunol Methods (2008) 0.84
Albumin fusion of thioredoxin--the production and evaluation of its biological activity for potential therapeutic applications. J Control Release (2010) 0.84
Identification of human liver cytochrome P450 isoforms involved in autoinduced metabolism of the antiangiogenic agent (Z)-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid (TSU-68). Drug Metab Dispos (2008) 0.84
Antioxidant protection of human serum albumin by chitosan. Int J Biol Macromol (2008) 0.84
Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation. Biochem Biophys Res Commun (2007) 0.84
Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier. Drug Metab Dispos (2009) 0.84
Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study. Clin Biochem (2008) 0.84
Quantitative evaluation of the role of cysteine and methionine residues in the antioxidant activity of human serum albumin using recombinant mutants. IUBMB Life (2012) 0.84
Decrease in plasma concentrations of antiangiogenic agent TSU-68 ((Z)-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid) during oral administration twice a day to rats. Drug Metab Dispos (2007) 0.83
Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. J Neurochem (2006) 0.83
Alpha1-acid glycoprotein suppresses rat acute inflammatory paw edema through the inhibition of neutrophils activation and prostaglandin E2 generation. Biol Pharm Bull (2007) 0.83
Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin. Clin Exp Nephrol (2013) 0.83
Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res (2005) 0.83
S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding. J Biol Chem (2008) 0.83
Kinetic analysis of covalent binding between N-acetyl-L-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro. Pharm Res (2002) 0.83
Physicochemical characterization of cross-linked human serum albumin dimer and its synthetic heme hybrid as an oxygen carrier. Biochim Biophys Acta (2004) 0.83
A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate. Biochem Pharmacol (2012) 0.83
Updates on contemporary protein binding techniques. Drug Metab Pharmacokinet (2009) 0.82
Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin. J Pharm Sci (2010) 0.82
Recombinant human serum albumin dimer has high blood circulation activity and low vascular permeability in comparison with native human serum albumin. Pharm Res (2006) 0.82
Characterization of ligand binding sites on the alpha1-acid glycoprotein in humans, bovines and dogs. Drug Metab Pharmacokinet (2002) 0.82
Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats. J Pharmacol Exp Ther (2005) 0.82
Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites. Drug Metab Dispos (2005) 0.81
Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats. Biopharm Drug Dispos (2003) 0.81
New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant. Ther Apher Dial (2011) 0.81
S-guanylation of human serum albumin is a unique posttranslational modification and results in a novel class of antibacterial agents. J Pharm Sci (2012) 0.81
Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo. Pharm Res (2003) 0.81
Binding of alpha1-acid glycoprotein to membrane results in a unique structural change and ligand release. Biochemistry (2004) 0.81
Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model. J Control Release (2009) 0.81
Albumin domain II mutant with high bilirubin binding affinity has a great potential as serum bilirubin excretion enhancer for hyperbilirubinemia treatment. Biochim Biophys Acta (2013) 0.81
Albumin fusion prolongs the antioxidant and anti-inflammatory activities of thioredoxin in mice with acetaminophen-induced hepatitis. Mol Pharm (2014) 0.81
Immunological detection of N omega-(Carboxymethyl)arginine by a specific antibody. Ann N Y Acad Sci (2007) 0.80
Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression. J Pharmacol Exp Ther (2013) 0.80
Pharmaceutically important pre- and posttranslational modifications on human serum albumin. Biol Pharm Bull (2009) 0.80
The uremic solute indoxyl sulfate acts as an antioxidant against superoxide anion radicals under normal-physiological conditions. FEBS Lett (2010) 0.80
Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. J Pharmacol Exp Ther (2002) 0.80
Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial (2011) 0.80
Biological characteristics of two lysines on human serum albumin in the high-affinity binding of 4Z,15Z-bilirubin-IXα revealed by phage display. FEBS J (2011) 0.80
Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p-cresol on losartan metabolism in vitro. J Pharm Pharmacol (2010) 0.80
Hypochlorous acid generates N epsilon-(carboxymethyl)lysine from Amadori products. Free Radic Res (2007) 0.79
Biological Responsiveness and Metabolic Performance of Liposome-Encapsulated Hemoglobin (Hemoglobin-Vesicles) in Apolipoprotein E-Deficient Mice after Massive Intravenous Injection. Biol Pharm Bull (2015) 0.79
Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats. Life Sci (2012) 0.79
Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin. Drug Metab Dispos (2007) 0.79
Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model. Life Sci (2012) 0.79
Cloning, expression and tissue distribution of a tetrameric form of pig carbonyl reductase. Chem Biol Interact (2003) 0.79